Literature DB >> 23128938

Effects of IL-1β on the proliferation and apoptosis of gastric epithelial cells and acid secretion from isolated rabbit parietal cells.

Tao Guo1, Jia-Ming Qian, Yu-Qing Zhao, Xiao-Bo Li, Jian-Zhong Zhang.   

Abstract

The aim of the present study was to explore the effects of IL-1β on the proliferation and apoptosis of gastric epithelial cells and acid secretion from isolated rabbit parietal cells. The mechanisms by which these effects are mediated were also investigated. Parietal cells were isolated from rabbit gastric mucosa by elutriation. The AGS human gastric cancer cell line, the GES-1 human gastric epithelial cell line and parietal cells were treated with interleukin (IL)-1β in the presence or absence of Helicobacter pylori (H. pylori) for the times indicated. MTT assay and flow cytometry (FCM) were used to determine the levels of proliferation and apoptosis. The expression levels of cyclooxygenase-2 (COX-2) mRNA and protein were examined by RT-PCR and FCM. Acid secretion by parietal cells was examined using 14C-aminopyrine (14C‑AP) accumulation. H+/K+ATPase α subunit mRNA expression was assessed by RT-PCR. The results demonstrated that IL-1β (10 ng/ml) stimul-ated cellular proliferation and inhibited H. pylori-induced apoptosis in GES-1 and AGS cell lines. IL-1β (10 ng/ml) upregulated the mRNA and protein expression of COX‑2 in GES-1 and AGS cells. Acid secretion stimulated by histamine was identified as significantly inhi-bited and mRNA expression of H+/K+ATPase α subunit was downregulated by treatment with IL-1β (10 ng/ml) for 30 min and 16 h compared with the control in isolated rabbit parietal cells. The present study demonstrates that IL-1β plays a significant role in H. pylori-induced gastric carcinogenesis through 2 main mechanisms: i) IL-1β may interfere in gastric epithelial cell growth by upregulating COX-2 expression; ii) IL-1β may inhibit the acid secretion from parietal cells by downregulating H+/K+ATPase expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23128938     DOI: 10.3892/mmr.2012.1165

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Physiological implications of biased signaling at histamine H2 receptors.

Authors:  Natalia Alonso; Carlos D Zappia; Maia Cabrera; Carlos A Davio; Carina Shayo; Federico Monczor; Natalia C Fernández
Journal:  Front Pharmacol       Date:  2015-03-10       Impact factor: 5.810

3.  Analysis of cell hyperplasia and parietal cell dysfunction induced by Ostertagia ostertagi infection.

Authors:  Belgacem Mihi; Frederik Van Meulder; Manuela Rinaldi; Stefanie Van Coppernolle; Koen Chiers; Wim Van den Broeck; Bruno Goddeeris; Jozef Vercruysse; Edwin Claerebout; Peter Geldhof
Journal:  Vet Res       Date:  2013-12-11       Impact factor: 3.683

4.  Molecular mechanisms of Wischnewski spot development on gastric mucosa in fatal hypothermia: an experimental study in rats.

Authors:  Chihpin Yang; Kana Sugimoto; Yukie Murata; Yuichiro Hirata; Yu Kamakura; Yoshihisa Koyama; Yohei Miyashita; Kentaro Nakama; Kazuma Higashisaka; Kazuo Harada; Ryuichi Katada; Hiroshi Matsumoto
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

Review 5.  The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis.

Authors:  Farzaneh Fakharian; Behnoush Asgari; Ali Nabavi-Rad; Amir Sadeghi; Neda Soleimani; Abbas Yadegar; Mohammad Reza Zali
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

Review 6.  Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer.

Authors:  Jun-Bo Hong; Wei Zuo; An-Jiang Wang; Nong-Hua Lu
Journal:  Int J Med Sci       Date:  2016-04-08       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.